{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:54:13Z","timestamp":1780970053160,"version":"3.54.1"},"reference-count":42,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>[18F]FDG-PET\/CT is a useful tool for diagnosis and cancer detection in idiopathic inflammatory myopathies (IIMs), especially polymyositis (PM) and dermatomyositis (DM). Data deriving from Europe are lacking. We describe [18F]FDG-PET\/CT results in a Belgian cohort with IIMs, focusing on patients with PM and DM. All of the cases of IIMs admitted between December 2010 and January 2023 to the Cliniques Universitaires Saint-Luc (Belgium) were retrospectively reviewed. In total, 44 patients were identified with suspected IIMs; among them, 29 were retained for final analysis. The mean age of the retained patients was 48.7 years; 19 patients were female (65.5%). Twenty-two patients had DM and seven had PM. The mean serum creatinine kinase (CK) and the mean CRP levels were 3125 UI\/L and 30.3 mg\/L, respectively. [18F]FDG-PET\/CT imaging was performed for 27 patients, detecting interstitial lung diseases (ILDs) in 7 patients (25.9%), cancer in 3 patients (11.1%), and abnormal muscle FDG uptake compatible with myositis in 13 patients (48.1%). All of the patients who were detected to have ILDs via PET\/CT imaging were confirmed using a low-dose lung CT scan. Among the patients who were detected to have abnormal muscle FDG uptake via PET\/CT scans (13\/28), the EMG was positive in 12 patients (p = 0.004), while the MRI was positive in 8 patients (p = 0.02). We further observed that there was a significantly higher level of CK in the group with abnormal muscle FDG uptake (p = 0.008). Our study showed that PET\/CT is useful for detecting cancer and ILDs. We showed that the detection of abnormal muscle uptake via PET\/CT was in accordance with EMG and MRI results, as well as with the mean CK value, and that the presence of dyspnea was significantly associated with the presence of ILDs detected via PET\/CT imaging (p = 0.002).<\/jats:p>","DOI":"10.3390\/diagnostics13142316","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:47:35Z","timestamp":1688950055000},"page":"2316","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["[18F]FDG-PET\/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3103-1638","authenticated-orcid":false,"given":"Halil","family":"Yildiz","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Institute of Clinical and Experimental Research (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, B-1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lepere","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital d\u2019Arlon (Vivalia), 6700 Arlon, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Zorzi","sequence":"additional","affiliation":[{"name":"Department of Laboratory, Avenue Hippocrate 10, B-1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gheysens","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cliniques Universitaires Saint-Luc, Institute of Clinical and Experimental Research (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, B-1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Roodhans","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Institute of Clinical and Experimental Research (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, B-1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Pothen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Infectious Diseases, Cliniques Universitaires Saint-Luc, Institute of Clinical and Experimental Research (IREC), Universit\u00e9 Catholique de Louvain (UCLouvain), Avenue Hippocrate 10, B-1200 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"883727","DOI":"10.3389\/fmed.2022.883727","article-title":"The Role of Quantitative and Semi-quantitative [(18)F]FDG-PET\/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis","volume":"9","author":"Yildiz","year":"2022","journal-title":"Front. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: An important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/rir-2022-0001","article-title":"Myositis-specific Antibodies: Overview and Clinical Utilization","volume":"3","author":"Halilu","year":"2022","journal-title":"Rheumatol. Immunol. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imj.15358","article-title":"Idiopathic inflammatory myopathies: A review","volume":"51","author":"Ashton","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Milisenda","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pmr.2012.08.017","article-title":"Electrodiagnostic evaluation of myopathies","volume":"24","author":"Paganoni","year":"2013","journal-title":"Phys. Med. Rehabil. Clin. N. Am."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e12954","DOI":"10.1111\/bpa.12954","article-title":"MRI and muscle imaging for idiopathic inflammatory myopathies","volume":"31","author":"Malartre","year":"2021","journal-title":"Brain Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2016-210198","article-title":"Thigh muscle MRI in immune-mediated necrotising myopathy: Extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity","volume":"76","author":"Carrino","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/mus.24661","article-title":"Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis","volume":"52","author":"Tasca","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/rheumatology\/kem088","article-title":"The role of MRI in the assessment of polymyositis and dermatomyositis","volume":"46","author":"Charvat","year":"2007","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Palmucci, S., Di Mari, A., Cancemi, G., Pennisi, I., Mauro, L.A., Sambataro, G., Sambataro, D., Galioto, F., Fazio, G., and Ferlito, A. (2022). Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis. Medicina, 58.","DOI":"10.3390\/medicina58121757"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.semarthrit.2018.10.021","article-title":"Positron emission tomography costs less to patients than conventional screening for malignancy in dermatomyositis","volume":"49","author":"Kundrick","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"152107","DOI":"10.1016\/j.semarthrit.2022.152107","article-title":"Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review","volume":"57","author":"Bentick","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3899\/jrheum.111597","article-title":"Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis","volume":"39","author":"Owada","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e006763","DOI":"10.1136\/bmjopen-2014-006763","article-title":"Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: Imaging of skeletal muscle inflammation","volume":"5","author":"Tateyama","year":"2015","journal-title":"BMJ Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1346-8138.14758","article-title":"Clinical value of (18) F-fluorodeoxyglucose positron emission tomography\/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis","volume":"46","author":"Motegi","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","article-title":"Multiple values of (18)F-FDG PET\/CT in idiopathic inflammatory myopathy","volume":"36","author":"Li","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41824-020-00084-w","article-title":"(18)F-FDG PET\/CT in patients with polymyositis\/dermatomyositis: Correlation with serum muscle enzymes","volume":"4","author":"Norikane","year":"2020","journal-title":"Eur. J. Hybrid Imaging"},{"key":"ref_25","first-page":"5023","article-title":"[(18)F]Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosing polymyositis\/dermatomyositis","volume":"15","author":"Sun","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1093\/rheumatology\/kez040","article-title":"Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity: Reply","volume":"58","author":"Matuszak","year":"2019","journal-title":"Rheumatology"},{"key":"ref_27","first-page":"570","article-title":"18F-Fluorodeoxyglucose positron emission tomography for the assessment of myositis: A case series","volume":"30","author":"Pipitone","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1007\/s00330-019-06302-9","article-title":"Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis","volume":"29","author":"Martis","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e03707","DOI":"10.1016\/j.heliyon.2020.e03707","article-title":"Value of (18)F-FDG PET\/CT in the detection of occult malignancy in patients with dermatomyositis","volume":"6","author":"Li","year":"2020","journal-title":"Heliyon"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","article-title":"The lungs were on fire: A pilot study of (18)F-FDG PET\/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"779272","DOI":"10.3389\/fmed.2021.779272","article-title":"Radiological Characteristics of Patients With Anti-MDA5-Antibody-Positive Dermatomyositis in (18)F-FDG PET\/CT: A Pilot Study","volume":"8","author":"Cao","year":"2021","journal-title":"Front. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00259-004-1757-9","article-title":"The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease","volume":"32","author":"Walter","year":"2005","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Grau","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"151940","DOI":"10.1016\/j.semarthrit.2021.12.008","article-title":"Cancer screening in idiopathic inflammatory myopathies: Ten years experience from a single center","volume":"53","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42466-022-00213-9","article-title":"PET-MRI in idiopathic inflammatory myositis: A comparative study of clinical and immunological markers with imaging findings","volume":"4","author":"Girija","year":"2022","journal-title":"Neurol. Res. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl. Med. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.41566","article-title":"Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis\/Dermatomyositis-Associated Interstitial Lung Disease","volume":"73","author":"Gono","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/rheumatology\/keaa372","article-title":"Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: A retrospective study of 679 adult cases","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.autrev.2018.07.013","article-title":"Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis","volume":"18","author":"Barba","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1007\/s10067-022-06239-3","article-title":"18F-FDG PET\/CT and HRCT: A combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"41","author":"Zhang","year":"2022","journal-title":"Clin. Rheumatol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/14\/2316\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:09:13Z","timestamp":1760126953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/14\/2316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":42,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["diagnostics13142316"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13142316","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,8]]}}}